The global bone grafts and substitutes market size was estimated at USD 3.34 billion in 2025 and is projected to reach USD 5.50 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. Increasing utilization of bone grafts and substitutes in various applications such as spinal fusion, orthopedic fracture healing, periodontal defect repair, dental alveolar ridge augmentation, and wound care with skin equivalents primarily drives the growth of this market.
Significant technological advancements, the emergence of synthetic bone grafts, the availability of novel surgical solutions, and substantial changes in regenerative medicine are expected to develop lucrative growth opportunities for the bone grafts and substitutes market.
Increasing demand for synthetic bone grafts, primarily driven by factors such as risks of infection and limited supply, has stimulated new product developments and growing efforts focused on R&D associated with bone grafts. Moreover, the launch of innovation-based solutions by prominent manufacturers indicates the growth potential of this market. For instance, in December 2025, Xtant Medical Holdings, Inc., a surgical solutions provider for spinal and other orthopedic conditions, announced the launch of its latest offering, nanOss strata-synthetic bone graft, which is developed with hydroxycarbonapatite (HCA), a material characterized by higher solubility as compared to traditional hydroxyapatite. Such developments are likely to support industry growth in the forecast period.
The increasing use of bone grafts in dentistry is adding to the growth potential of the dental bone grafts and substitutes market. Furthermore, dental implant surgery has become very popular with advanced surgical techniques, such as bone grafts and bone regeneration. Moreover, dental implants are the most preferred solution for individuals experiencing tooth-based conditions. both practitioner skills and the emerging technology supporting dental implants continue to evolve.
However, shifting trends and inclination among dental practitioners towards offering convenience without compromising patient safety, multiple manufacturers in this industry have been adding innovative products to their product lines. For instance, in February 2025, one of the key participants in regenerative medicine and the life sciences industry, LifeNet Health, introduced OraGen, a viable dental bone allograft, equipped with cryopreserved corticocancellous bone comprising endogenous lineage. Such product launches and accessibility to solutions that improve the effectiveness of dental procedures are projected to fuel the market growth.
Use of bioactive peptides, which enable natural healing while significantly reducing the risk of unwanted ectopic bone growth.
Digital integration, imaging-guided surgeries, and the use of AI-powered tools ensure precise procedures while ensuring lower recovery time.
Furthermore, a supportive regulatory framework is anticipated to support the bone grafts and substitutes market potential. For instance, the Breakthrough Device Program by the U.S. FDA focuses on helping the acceleration of development and review of innovative devices that offer enhanced treatments for lethal or irreversibly debilitating medical conditions. In October 2024, Amphix Bio, a company engaged in the development of regenerative medicine, announced that the FDA granted Breakthrough Device designation to its off-the-shelf bone graft substitute, AMFX 100. Such advancements and supportive government programs are fueling the market growth.
Rising adoption of minimally invasive procedures is further escalating the demand for bone grafts and substitutes. Surgeons are choosing minimally invasive procedures instead of open or traditional approaches owing to various benefits associated with MIS, such as quick procedure, less recovery time, shorter hospital stays, and fewer incisions. According to data from the American Academy of Orthopedic Surgeons (AAOS), the number of minimally invasive orthopedic procedures performed in the U.S. has been increasing steadily over the years. Some of the commonly performed minimally invasive orthopedic procedures in the U.S. are arthroscopy, spine surgeries, fracture repair, and joint replacement procedures. Thus, a rising number of MIS is anticipated to drive the global bone grafts and substitutes market at a significant pace.
Significant technological advancements, the emergence of synthetic bone grafts, the availability of novel surgical solutions, and substantial changes in regenerative medicine are expected to develop lucrative growth opportunities for the bone grafts and substitutes market.
Increasing demand for synthetic bone grafts, primarily driven by factors such as risks of infection and limited supply, has stimulated new product developments and growing efforts focused on R&D associated with bone grafts. Moreover, the launch of innovation-based solutions by prominent manufacturers indicates the growth potential of this market. For instance, in December 2025, Xtant Medical Holdings, Inc., a surgical solutions provider for spinal and other orthopedic conditions, announced the launch of its latest offering, nanOss strata-synthetic bone graft, which is developed with hydroxycarbonapatite (HCA), a material characterized by higher solubility as compared to traditional hydroxyapatite. Such developments are likely to support industry growth in the forecast period.
The increasing use of bone grafts in dentistry is adding to the growth potential of the dental bone grafts and substitutes market. Furthermore, dental implant surgery has become very popular with advanced surgical techniques, such as bone grafts and bone regeneration. Moreover, dental implants are the most preferred solution for individuals experiencing tooth-based conditions. both practitioner skills and the emerging technology supporting dental implants continue to evolve.
However, shifting trends and inclination among dental practitioners towards offering convenience without compromising patient safety, multiple manufacturers in this industry have been adding innovative products to their product lines. For instance, in February 2025, one of the key participants in regenerative medicine and the life sciences industry, LifeNet Health, introduced OraGen, a viable dental bone allograft, equipped with cryopreserved corticocancellous bone comprising endogenous lineage. Such product launches and accessibility to solutions that improve the effectiveness of dental procedures are projected to fuel the market growth.
Some of the key technological advancements expected to boost market growth are:
Development of patient-specific, customized scaffolds using 3D printing.Use of bioactive peptides, which enable natural healing while significantly reducing the risk of unwanted ectopic bone growth.
Digital integration, imaging-guided surgeries, and the use of AI-powered tools ensure precise procedures while ensuring lower recovery time.
Furthermore, a supportive regulatory framework is anticipated to support the bone grafts and substitutes market potential. For instance, the Breakthrough Device Program by the U.S. FDA focuses on helping the acceleration of development and review of innovative devices that offer enhanced treatments for lethal or irreversibly debilitating medical conditions. In October 2024, Amphix Bio, a company engaged in the development of regenerative medicine, announced that the FDA granted Breakthrough Device designation to its off-the-shelf bone graft substitute, AMFX 100. Such advancements and supportive government programs are fueling the market growth.
Rising adoption of minimally invasive procedures is further escalating the demand for bone grafts and substitutes. Surgeons are choosing minimally invasive procedures instead of open or traditional approaches owing to various benefits associated with MIS, such as quick procedure, less recovery time, shorter hospital stays, and fewer incisions. According to data from the American Academy of Orthopedic Surgeons (AAOS), the number of minimally invasive orthopedic procedures performed in the U.S. has been increasing steadily over the years. Some of the commonly performed minimally invasive orthopedic procedures in the U.S. are arthroscopy, spine surgeries, fracture repair, and joint replacement procedures. Thus, a rising number of MIS is anticipated to drive the global bone grafts and substitutes market at a significant pace.
The increasing incidence of bone disorders due to road accidents and sports injuries is driving the bone grafts and substitutes industry. Bone grafts can be used for the following purposes:
To repair a broken bone
To repair previously injured bone that has not healed.Spinal fusion (in case of an unstable spine)
Bone regeneration
To heal the bone around surgical implantation (joint & knee replacement)
Global Bone Grafts And Substitutes Market Report Segmentation
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global bone grafts and substitutes market report based on material type, application, and region:- Material Type Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
- Allograft
- Demineralised Bone Matrix
- Others
- Synthetic
- Ceramics
- HAP
- ß-TCP
- α-TCP
- bi-phasic calcium phosphates (BCP)
- Others (calcium sulphates, tricalcium phosphate)
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)
- Application Outlook (Revenue USD Million, 2021-2033)
- Craniomaxilofacial
- Dental
- Foot and Ankle
- Joint Reconstruction
- Long Bone
- Spinal Fusion
- Regional Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021-2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
Table of Contents
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Bone Grafts and Substitutes Market Variables and Trends
Chapter 4 Bone Grafts and Substitutes Market: Material Type Estimates & Trend Analysis (Revenue in USD Million, Unit Volume in Thousand Units)
Chapter 5 Bone Grafts and Substitutes Market: Application Estimates & Trend Analysis
Chapter 6 Bone Grafts and Substitutes Market: Regional Estimates & Trend Analysis
Chapter 7 Bone Grafts and Substitutes Market: Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- AlloSource
- DePuy Synthes (Johnson & Johnson)
- Baxter
- NuVasive, Inc.
- Smith + Nephew
- Medtronic
- Orthofix Medical, Inc.
- OST Laboratories
- Zimmer Biomet
- Geistlich Pharma AG
- Stryker
- Biobank
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 150 |
| Published | March 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 3.34 Billion |
| Forecasted Market Value ( USD | $ 5.5 Billion |
| Compound Annual Growth Rate | 5.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
